Siemens Healthineers AG Stock News

Siemens Healthineers AG (OTCPK:SEMHF) Q2 2023 Earnings Conference Call May 10, 2023 2:30 AM ET Company Participants Marc Koebernick - Head, Investor Relations Bernhard Montag - Chief Executive Officer

Bernd Montag, CEO at Siemens Healthineers, says the company will see positive topline growth and improved pricing kick in on the bottom line.

Siemens Healthineers AG (OTCPK:SEMHF) Q1 2023 Earnings Conference Call February 2, 2023 2:30 AM ET Company Participants Marc Koebernick - Head of Investor Relations Bernd Montag - Chief Executive Offi

Siemens Healthineers AG expects strong growth in both revenue and earnings per share through fiscal 2025. The company pays a dividend and buys back shares; the dividend yield is currently about 1.9% a

Siemens Healthineers AG and General Electric Co's healthcare business are weighing a potential acquisition of two units being spun off by Medtronic Plc, Bloomberg news reported on Thursday, citing peo

Siemens Healthineers AG (OTCPK:SEMHF) Q4 2022 Earnings Conference Call November 9, 2022 2:30 AM ET Company Participants Marc Koebernick - Head, IR Bernd Montag - President, CEO and Chairman Jochen Sch

Bernd Montag, CEO at Siemens Healthineers, discusses earnings, the economic challenges facing the company over the next quarter, and the impact of the U.S. midterm elections on the business.

Siemens Healthineers on Wednesday posted rising earnings and revenue for the fourth quarter of its fiscal year that beat expectations, driven by the imaging division.

Siemens Healthineers underwhelmed in its latest quarterly earnings report amid the ongoing supply-side challenges. Given the earnings headwinds are transitory rather than structural, the long-term inv

Siemens Healthineers AG (OTCPK:SEMHF) Q3 2022 Earnings Conference Call August 3, 2022 2:30 AM ET Company Participants Marc Koebernick - Head, IR Bernhard Montag - President, CEO & Chairman Jochen Schm

U.S.-German medical device maker Siemens Healthineers stuck with its outlook for the 2022 financial year on Wednesday as supply-chain headwinds and COVID-19 lock-downs pushed some sales into next quar

Siemens Healthineers AG is a subsidiary of Siemens AG and a leading medical technology company. The company designs, develops, manufactures and markets sophisticated healthcare solutions for a broad r

Siemens Healthineers AG (OTCPK:SEMHF) Q2 2022 Earnings Conference Call May 4, 2022 2:00 AM ET Company Participants Marc Koebernick - IR Bernd Montag - CEO Jochen Schmitz - CFO Conference Call Particip

U.S.-German medical device maker Siemens Healthineers raised its 2022 targets on Wednesday due to increased demand for rapid COVID-19 antigen tests, and reported a rise in first-quarter revenue and ea

WASHINGTON, March 11, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Heart Failure POC & LOC Devices Market finds that factors such as, increasing geriatric population base, growing research & development activities and rising cardiovascular diseases are augmenting the growth of Heart Failure POC & LOC Devices Market in upcoming time span. The total Global Heart Failure POC & LOC Devices Market is estimated to reach USD 180.1 Million by 2028. The Market stood at a revenue of USD 55.9 Million in the year 2021, and is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 16.5%, states Vantage Market Research, in a report, titled " Heart Failure POC & LOC Devices Market by Test Type (Proteomic Testing, Metabolomic Testing, Genomic Testing), by Technology (Microfluidics, Array-based Systems, Others), by End Use (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".